Fostamatinib, sold under the brand names Tavalisse and Tavlesse, is a tyrosine kinase inhibitor medication for the treatment of chronic immune thrombocytopenia (ITP). The drug is administered by mouth.
via Wikipedia infobox
via PubChem
via Wikidata · CC0
{{Infobox drug | drug_name = | INN = | type = | image = Fostamatinib.svg | image_class = skin-invert-image | width = | alt = | caption =
| pronounce = | tradename = Tavalisse, Tavlesse | Drugs.com = | MedlinePlus = a618025 | licence_CA = | licence_EU = yes | DailyMedID = Fostamatinib | licence_US = | pregnancy_AU = | pregnancy_AU_comment = | pregnancy_category = Not recommended | routes_of_administration = By mouth | class = | ATCvet = | ATC_prefix = B02 | ATC_suffix = BX09 | ATC_supplemental =
Discovered by embedding cosine similarity (sentence-transformers MiniLM, 384-dim).